Insider Purchases: Inside the Buy
Tag: HealthTech

This Wound Care Stock Doesn't Have to Hurt! 🩸🩼
CEO Joseph Capper is buying big. The company’s 9% full-year sales growth and 20%+ EBITDA margins suggest something’s brewing at this placental powerhouse. From PURION™ to profitability—this is wound care with a serious upside.
Quick links
Search
Privacy Policy
Refund Policy
Shipping Policy
Terms of Service
Contact us
About us
FUNanc!al distills the fun in finance and the finance in fun, makes news personal, and helps all reach happiness.